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SInce the HIV primary infection the viral activity is continuous, and it produces the rise of a series of markers which will reflect the 
probability of HIV development at a certain speed. These markers show 
in a direct way (viral load, or lymphocytes T CD4) or in an indirect way 
(microglobulin ß-2, neopterin, or antigen p24) the action HIV takes 
on the immunological system of the patient, and they have been used 
independently or combined to identify the risk of progression to AIDS 
[9] (Table I).
All these markers have a high prognostic value. In the case of 
lymphocytes T CD4, their number is the main indicator of the patient’s 
immunological state. Its count is used for staging HIV infection, 
evaluating the risk of comorbidity or mortality, and the vulnerability 
to certain oportunistic infections, the need for its prophylaxis and 
the occasional discontinuation [1] [15]. Nowadays, the universal 
indication of anti-retroviral treatment (ART) is recognised for all 
patients, regardless of the lymphocyte CD4 count. Thus, the absolute 
number and the percentage of lymphocytes CD4 must be periodically 
determined before initiating ART and, once it has been initiated, as a 
parameter of periodical monitoring of the immunological response to 
said treatment [15].
As far as the viral load is concerned, it must be determined during 
the initial assessment of the patient and before the beginning of ART, 
being the main parameter for the evaluation of ART’s virological 
efficacy and to define the virological failure [7]. For all these reasons, 
we can conclude that the combination of these markers allows us to 
obtain a better overview of a patient’s state, his/her prognosis and his/
her response to treatment.
HIV may affect the cognitive development of these patients [10], 
these specific markers have been studied regarding the presence 
of neuropsychological affectation, although results are not very 
consistent. As far as immunological markers are concerned, the 
lymphocyte T CD4 rate of decrease is a good indicator to determine the 
probability of developing AIDS [2] [27] [36], however, its efficiency 
to predict neurological and neuropsychological affectation has not 
been confirmed. While some authors point out that the probability of 
developing neuropsychological affectation is higher among seropositive 
patients with low levels of lymphocytes CD4 [26] [28] [29] [15], 
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others, on the contrary, claim that there is no connection between the 
rate of lymphocytes T CD4 and neuropsychological functioning [14] 
[19] [21] [34]. In the end, immunological markers of HIV infection, 
specifically lymphocyte T CD4 count, have been associated to the 
presence of neuropsychological affectation in seropositive patients, 
though there does not seem to be an agreement about this in literature, 
which suggests the need for continuing research in order to clarify this 
subject.
For all these reasons, the objective of this article is to study 
the connection between lymphocytes T CD4 levels and the 
neuropsychological performance of former seropositive drug addicts.
taBle I 
MaIn BIologIcal MaRkeRs of hIv InfectIon  




It is considered a severe immunodepression when the 
lymphocyte CD4 number, its percentage or the quotient 
CD4/CD8 is lower than 200/mm3, 15% or 0,3 respectively.
Microglobulin 
ß-2:
It is present in all the nucleated cells, including lymphocytes 
and macrofages. Its serum increase reflects the activation of 
these cells. In homosexuals infected with HIV it has been 
observed a progression of the infection when the plasmatic 
levels are higher than 5 g/ml. The results in drug addicts are 
contradictory.
Neopterin:
It is produced by monocytes and macrofages stimulated with 
interferon gamma produced by the activated lymphocytes 
T. In HIV-infected homosexuals it has been observed a 
progression of the infection with plasmatic levels higher 
than 20 nmol/l. The results in drug addicts are variable.
Virological markers
Antigen p24:
It is detected at the beginning (acute infecction) and at the 
end (AIDS) of the infection. It is not detected when the 
patient has lymphocytes T CD4 higher than 500/mm3. Its 
apparition in an asymptomatic patient is a biological marker 
of progression. It is seldom used at present.
Viral load:
Measured through PCR (detection limit 200 copies/ml), 
bDNA (detection limit 500 copies/ml) y NASBA (detection 
limit 50 copies/ml) from plasma or serum. Viral load is the 
best prognostic and treatment-monitoring indicator. 
II. Methodology
A. Subjects
This study is part of another one done on a wider population [32]. In 
order to conduct this research we have used a sample which comprised 
80 males with a previous history of substance use, who voluntarily 
took part in the study, giving their informed consent. All the subjects 
for this study are former drug addicts with HIV infection. They were 
recruited at the Montecelo Hospital in Pontevedra, Xeral Cíes Hospital 
in Vigo, Xeral de Galicia Hospital in Santiago de Compostela and Juan 
Canalejo Hospital in A Coruña. 
For the selection of the sample the professionals in the reference 
centres were informed of the requirements which the subjects for 
our study had to meet, and once selected, they were called at the 
centre, where the researcher informed them of the characteristics 
of the research, asking for their cooperation, and offering them the 
presentation of a report with all the results of the evaluation once it was 
complete. The subjects interested in taking part gave their informed 
consent and were called for the evaluation at the same centre where 
they had been selected, although some of them preferred taking the 
tests at the Faculty of Psychology in Santiago de Compostela. 
We excluded from the study those subjects who showed, or had 
shown, neurological or medical pathologies that could affect the 
central nervous system, including dementia associated with HIV; 
psychiatric disorders; history of head trauma requiring hospitalization 
due to neurological complications; and antisocial personality disorder 
according to DSM-IV criteria (American Psychiatric Association, 
1995). Also, we excluded subjects with moving or sensory defects, 
except in the case of visual ones corrected with lenses. Finally, based 
on the report from the professionals at the drug addict assistance units 
and the self-report from the subjects itself, we excluded those patients 
currently using psychotropic substances (illegal, medicine or alcohol) 
different from methadone.
Regarding the socio-demographic characteristics of the sample, 94% 
of the subjects presented right-hand dominance and 6% left-handed. 
60% had primary studies, and the remaining 40% secondary or higher 
studies. 33% had a low socioeconomic level, and 67% a medium level. 
In terms of work situation, 40% were working when the study took 
place, and 60% were unemployed or retired (see Table II).
taBle II.  















Primary 60% 55 (68.7)
Secondary or higher 40% 25 (31.3)
Job 
situation
Not working 60% 57 (71.2)
Working 40% 23 (28.8)
Economical 
level
Low 33% 35 (43.8)
Medium 67% 45 (56.3)
* Mean and standard deviation
Regarding the clinical characteristics of the sample, 39% of 
seropositive subjects were not having any antiretroviral treatment, 
unlike the remaining 61%; in terms of viral load, in 44% of the cases 
it was undetectable, whereas in 56% it was detectable. As far as 
lymphocyte T CD4 level is concerned, 25% of seropositive subjects 
had a count higher than 500, in 29% it was 200-499, and in 46% it was 
under 200 (see Table 3).
taBle III.  
















B. Tools for Neuropsychological Assessment
The tests included in the battery for neuropsychological exploration 
designed for this study were chosen because of their validity, and 
because they appeared to be sensitive to the neuropsychological 
deterioration in HIV-infected patients in other studies. We present 
below the list of tests used (Table 4) following the order of application, 
and clarifying the results collected with each test.
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taBle Iv. 
BatteRy of neuRoPsychologIcal exPloRatIon used
• WAIS IV: Comprehension, 
Similarities, Digit Span, 
Vocabulary, Digit Symbol, Block 
Design and Object Assembly
• Rey Auditory Verbal Learning Test
• Visual Search and Attention Test
• Trail-Making Test (parts A and B)
• Verbal Fluency Test
• Benton’s Visual Retention Test
• Boston Naming Test
• Stroop Test
• Purdue’s Pedgeboard Test
• Rey-Osterrieth Complex Figure
• Finger-Tapping Test
• Wisconsin Card-Sorting Test
1. Wechsler Adult Intelligence Scale [35]. We used the following 
subtests from the Wechsler Adult Intelligence Scale (WAIS IV): 
Comprehension, Similarities, Digit Span, Vocabulary, Digit 
Symbol, Block Design and Object Assembly.
• Comprehension Subtest. It assesses the degree of appreciation 
of past experience applied to everyday situations, and of 
internalization of culture, especially of moral or ethical values. 
It consists of twelve open-ended questions, 14 common sense 
and practical reasoning questions, and 3 proverb questions that 
the subject must explain.
• Similarities Subtest. It is a test for verbal formation of concepts, 
which assesses the ability to assimilate and classify similarities 
and differences between objects, facts or ideas. It requires 
comprehension and associative thinking skills. The subject is 
asked to explain what a series of word pairs presented to him/
her have in common.
• Digit Span Subtest. It consists of two parts: forward digit span, 
in which the subject must repeat some series of numbers in 
the same order, and backward digit span, in which the subject 
repeats other series of numbers in reverse order. It assesses 
immediate auditory memory (backward digit span), attention 
(forward digit span), and resistance to distraction.
• Vocabulary Subtest. The subject must tell the meaning of 40 
words presented to him in order of increasing difficulty, which 
allows us to assess classification and conceptualization skills. 
The score obtained in this test was also used to calculate the 
cognitive reserve.
• Digit Symbol Subtest. It assesses the ability to learn an 
unfamiliar task, visuomotor skill, the degree of persistence 
when doing an unattractive task, and the information processing 
speed. It consists of a sheet which shows the subject some 
numbers, from 1 to 9, corresponding to a symbol, and a part 
where the numbers are, and in which the subject must draw the 
symbol corresponding to each number, as fast as possible in a 
limited time.
• Block Design Subtest. It assesses visuomotor integration, 
visuospatial organization, execution speed, and non-
intellectual factors such as excessive care, impulsivity, and 
distraction. The task consists of having the subject perform a 
series of constructions according to a model using blocks and 
in a limited time.
• Object Assembly Subtest. It is a test for visuospatial organization 
speed and motor response, which assesses analysis skills and 
visual synthesis, visual and motor coordination. Sequential 
thinking also plays an important role in this test. The task 
consists of having the subject build figures from the pieces that 
he/she is given, in a limited time.
2. Rey’s Auditory Verbal Learning Test [24]. It involves the 
reading, by the examiner, of a list of 15 words, which the 
subject must evoke immediately afterwards, in five different 
trials; and during a sixth evocation after an interference task 
(reading of 15 more words). It allows us to obtain seven scores, 
corresponding to the number of words evoked during the first 
five trials, a total score resulting from the addition of those, 
as well as the difference between the fifth and the sixth trials. 
This test allows us to asses immediate memory, it provides us 
with a learning curve, reveals inclinations towards patterns 
of retroactive and proactive interference, and measures the 
memory capacity after an interference.
3. Visual Search and Attention Test [31]. It is a test of visual 
cancellation which allows us to obtain a measurement of visual 
search skills and sustained attention. It comprises 4 sheets in 
which the subject must recognise and point out a certain letter 
or symbol among a series of distracting stimuli. With this test 
we obtain a score corresponding to the number of hits of the 
last two sheets.
4. Trail-Making Test [22]. It assesses skills of visual search and 
visuoconceptual and visuomotor exploration. It also assesses 
attention, mental flexibility, perceptive-motor skill and 
information processing speed. It consists of two tasks with 
separated scores, the score being the time that the subject needs 
to complete each task:
• Trails A , consisting of 25 circles numbered from 1 to 25 that 
the subject must join correlatively with a pencil stroke. 
• Trails B , in which the 25 circles contain numbers from 1 to 
13 and letters from A to L, the subject must join alternatively 
numbers and letters. 
5. Verbal Fluency Test [6]. Its main objective is to assess verbal 
fluency. It consists of having the subject tell us as many words 
as possible starting with the letters F, A and S in three trials of 
one minute each. We get a score resulting from the addition of 
the number of words which the subject names with each letter.
6. Benton Visual Retention Test (Form C, Administration A) [5]. 
It assesses visuoconstructive skills, visual memory and visual 
perception, as well as spatial organization and visuospatial 
memory. It involves the presentation of ten sheets with printed 
figures for ten seconds each, asking the subject to reproduce them 
immediately once the stimulus sheet has been removed. This test 
gives us two scores: the number of sheets correctly reproduced, 
which measures the general efficiency of the execution, and the 
number of mistakes made.
7. Boston Naming Test [16]. It is a broad-spectrum figure-naming 
test, consisting of 60 sheets in which an object is represented, 
which the subject must name spontaneously, or with the help of 
a semantic or phonetic key. The score we obtain corresponds to 
the total number of figures named correctly.
8. Stroop Test [11]. It measures verbal fluency, cognitive efficiency, 
and the ability to inhibit stimuli which trigger automatic 
responses and, therefore, the ability to adapt perception and 
accommodate to new demands inhibiting a usual response in 
favour of an unusual one (cognitive flexibility). It consists of 
three sheets that the subject must read:
• In the first sheet, he/she must read the words red, green and 
blue printed in black ink, and randomly arranged in columns.
• In the second one, he/she must name the colour of ink with 
which some symbols “xxx” are printed. 
• Finally, in the third sheet, the words red, green and blue appear 
printed with ink of those same colours. The subject must say 
the colour of the ink regardless of the written word. 
A score is obtained for each sheet, consisting of the number of 
elements read in 45 seconds. We also calculate an interference 
score based on the score obtained in each sheet. 
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9. Purdue Pegboard Test [30]. It assesses manual dexterity (speed 
and precision) in activities involving wide hand, finger and arm 
movements, and psychomotor coordination. The test consists 
of having the subject place a series of pegs in the holes set in 
rows on a board, first with his/her non-dominant hand, then 
with his/her dominant hand, and finally with both hands. We 
get three scores from the number of pegs placed during each 
part of the task and we also get a score resulting from the 
addition of the three parts.
10. Rey-Osterrieth Complex Figure Test [25]. It assesses 
constructive ability and visual memory, and it also allows 
us to assess cognitive processing ability, taking into account 
problem-solving strategies and organization and planning 
abilities. The test consists of having the subject copy a figure 
and after three minutes, without previous warning, reproduce 
it by heart. We get a score from the accuracy of the copy and 
another one from the reproduction by heart, also valuing the 
time spent in each one of them, as well as the strategy followed 
to copy the figure.
11. Finger-Tapping Test [23]. It assesses control, and psychomotor 
speed. It involves a board with a button connected to a counter, 
and the subject must tap with his/her index finger for 10 
seconds. The final score is the average number of hits during 5 
trials. A score is obtained for each hand.
12. Wisconsin Card-Sorting Test [13]. It allows us to obtain an 
assessment of abstract thinking. It is considered a measurement 
of executive functions and cognitive flexibility, as it requires 
some abilities to develop and maintain the strategy which is 
most appropriate to solve a problem while the stimulation 
conditions are changing. This measurement is considered to be 
sensitive to the frontal function. It consists of four stimulus 
cards and 128 response cards containing diversely-shaped 
figures (circles, crosses, triangles, stars), colours (green, blue, 
red, yellow), and a varied number of figures (one, two, three, 
four). The subject must match the response cards with the 
stimulus cards, deducing the criteria to do so correctly from the 
information given by the examiner in each trial. With this test 
we get multiple performance scores connected to the different 
cognitive processes: number of categories completed, fails in 
maintaining the category (inability to maintain an appropriate 
strategy); percentage of perseverative responses (persistence 
in responding according to a wrong criterion); percentage of 
perseverative and non-perseverative mistakes; and percentage 
of responses at a conceptual level (conceptual efficiency). 
C. Procedure
Once the subject had fulfilled the criteria for taking part in the study, 
after getting some good therapeutic adherence, and before performing 
the neuropsychological exploration, we collected, according to 
the information provided by the subject’s self-report, information 
regarding the personal background and medical history of interest, as 
well as relevant information about their history of drug abuse. Then, 
if no reason was deduced from the information to exclude the subject 
from the study, we would initiate the neuropsychological exploration 
using the protocol described in the material section, following the 
instructions indicated by the corresponding application manuals. 
The  characteristics of the tests application were constant for every 
subject, and they were performed individually, in two sessions with the 
examiner of approximately 45 minutes.
III. Results
A. Lymphocytes T CD4
In order to determine the level of immune compromise in the 
neuropsychological performance, we have divided the seropositive 
subjects in three groups, according to the lymphocyte T CD4 level 
(>500, 499-200, <200) following the classification of the Centre for 
Disease Control (1992). The results are shown in Table 5, which presents 
the means and deviations typical from the groups in each one of the 
neuropsychological measures, and points out the relevant differences 
that have been observed, doing “post hoc” multiple comparison tests. 
In graphic 1 it is represented the performance of each group during the 
Fig. 1. Z scores from neuropsychological tests for seropositive drug addicts according to lymphocyte T CD4 level.
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different neuropsychological tasks, once the direct scores have been 
transformed into Z scores, and its direction has been corrected.
B. Discussion
The relation of lymphocyte T CD4 levels, used as immunological 
markers of the progression of HIV infection, have also been studied 
in connection with the presence of neuropsychological affectation, 
although the results are not consistent. While some studies point out 
that the lower the level of lymphocyte T CD4 in seropositive subjects, 
the greater the neuropsychological deterioration [26] [29] [28],  others, 
on the contrary, show that cognitive functioning is not connected at all 
with this immunological marker [14] [19] [21] [34].
As far as our research is concerned, we have noticed a selective 
effect of the level of immune compromise in some attention and 
memory tasks. Our findings show that seropositive subjects with 
higher immunodepression levels (CD4 <200/mm3) obtain a poorer 
performance than those whose lymphocyte T CD4 levels are within the 
range of normality, in the Auditory Verbal Learning Test, Visual Search 
and Attention Test, WAIS Digit Symbol, Benton Visual Retention 
Test, and Stroop Test, which leads us to suggest that only the subjects 
with a high degree of immune compromise are neuropsychologically 
vulnerable.
Taking into account our findings and the fact that the 
immunodepression level did not show its effect in verbal 
and denominational tasks, concept formation and reasoning, 
visuoconstructive skills, manual dexterity and motor speed, and frontal 
functions, we can suggest that the deterioration of the immunological 
system does not affect the neuropsychological performance in a general 
way, it does so in a selective way in attention and memory tasks.
These results are in accordance with those obtained in other studies 
with drug addict subjects during the different stages of infection [8] 
[28],  as well as those obtained with homosexual subjects [4] [18] 
taBle v 
scoRes oBtaIned By seRoPosItIve foRMeR dRug addIcts In the neuRoPsychologucal  
tests accoRdIng to lyMPhocyte t cd4 levels [Mean (standaRd devIatIon)]
HIV+






n = 37 F
WAIS Comprehension 13.40 (4.15) 14.13 (4.00) 14.19 (4.05) .26
WAIS Similarities 12.10 (6.08) 11.78 (4.58) 13.49 (4.87) .94
WAIS Forward Digit Span 6.00 (1.12) 5.78 (1.28) 5.95 (1.18) .20
WAIS Backward Digit Span 4.25 (1.07) 3.83 (1.23) 4.27 (0.90) 1.43
WAIS Vocabulary 42.30 (13.88) 41.91 (13.24) 42.32 (12.00) .00
WAIS Digit Symbol a 48.45 (14.55) 45.52 (16.31) 38.34 (12.80) 3.77
WAIS Block Design 34.55 (8.38) 29.96 (9.78) 29.43 (7.90) 2.48
WAIS Object Assembly 31.80 (5.03) 27.13 (10.54) 27.11 (8.53) 2.28
AVLT , 5-6 1.65 (1.87) 2.26 (1.60) 1.97 (2.07) .55
AVLT, total a 45.65 (6.41) 38.91 (8.07) 36.41 (10.08) 6.35
VSAT a 129.40 (25.92) 117.43 (39.55) 102.86 (36.19) 3.91
Trails A 43.20 (14.97) 45.61 (25.51) 48.38 (23.03) .37
Trails B 89.60 (41.28) 101.04 (59.89) 128.65 (76.96) 2.72
Verbal Fluency Test 28.95 (10.60) 29.43 (11.08) 28.03 (9.44) .14
BVRT, correct 7.25 (1.62) 6.13 (2.40) 5.95 (1.90) 2.92
BVRT, errors a 4.05 (2.95) 6.17 (4.10) 7.41 (4.17) 4.85
Boston Naming 54.63 (2.29) 53.23 (5.47) 51.30 (6.25) 2.63
Stroop 1 99.40 (19.12) 96.26 (22.44) 90.89 (17.33) 1.37
Stroop 2 a, c 68.75 (13.95) 67.57 (16.44) 55.54 (14.83) 6.92
Stroop 3 39.35 (10.40) 37.87 (14.61) 32.54 (11.78) 2.43
Stroop: interference -1.33 (8.31) -1.62 (8.29) -1.28 (7.28) .01
Purdue dominant 13.70 (2.36) 14.09 (2.33) 12.78 (2.72) 2.08
Purdue nondominant 13.30 (2.20) 13.09 (1.76) 11.81 (2.53) 3.76
ROCF: copy 31.30 (2.25) 29.89 (4.92) 30.55 (3.66) .73
ROCF: Delay b 17.25 (4.74) 12.96 (7.49) 15.22 (4.83) 3.17
Finger Tapping: dominant 42.81 (8.85) 41.60 (10.65) 42.24 (12.73) .06
Finger Tapping: nondominant 38.89 (7.95) 37.87 (8.87) 37.31 (10.47) .17
WCST Categories 4.15 (1.90) 3.83 (2.08) 3.22 (2.11) 1.50
WCST Learning -6.39 (12.36) -8.00 (10.45) -3.66 (7.54) 1.05
WCST % Perseveratice errors 20.39 (14.25) 19.16 (10.88) 22.94 (14.41) .61
WCST % Nonperseverative errors 14.67 (8.40) 17.58 (13.67) 18.13 (10.98) .64
WCST Maintain set 0.90 (1.17) 0.78 (0.95) 1.17 (1.50) .69
WCST Conceptual response 54.06 (23.15) 50.29 (23.32) 44.68 (22.40) 1.17
WCST Perseverative response 23.49 (18.50) 21.81 (13.58) 27.22 (19.19) .73
a) Differences between CD4 > 500 y CD4 < 200 (p < .05)
b) Differences between CD4 > 500 y CD4 499-200 (p < .05)
c) Differences between CD4 499-200 y CD4 < 200 (p < .05)
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[29], which describe problems of attention, verbal fluency and manual 
dexterity.
However, in some of the studies carried out with seropositive 
homosexuals, both asymptomatic and symptomatic, no connection 
between immune deterioration and neuropsychological performance 
has been described [3] [19] [21] [34], and Heaton and collaborators 
do not describe it either (1995) [14] with seropositive heterosexual 
subjects during different stages of the infection, despite having used 
the same neuropsychological tasks as we did.
Our hypothesis is that the differences between the results obtained in 
these studies and ours can be due not only to the fact of using different risk 
groups, but also to the classification used to determine immunodepression 
levels. In this regard, some authors use as an immunodepression criterion 
values under 400 or 500 lymphocytes T CD4/mm3 [21], whereas we 
have grouped together the subjects according to the current classification 
of HIV infection (CDC, 1992) which provides three differencial levels 
of immunodepression. That is why when using levels of immune 
compromise with broader ranges the possibility of finding differences in 
the neuropsychological performance are reduced. On the other hand, we 
also must consider that some studies argue that lymphocytes T CD4 are 
the best immunological marker of neuropsychological deterioration in 
seropositive drug addicts [36], while in homosexuals the best predictor 
seems to be microglobulin ß-2 [17] 
On balance, our results support a direct relation between the 
lymphocyte T CD4 rate and the neuropsychological performance 
in seropositive people with a previous history of substance use in 
attention and memory tasks, whereas we do not observe this relation 
in the rest of skills assessed, which allows us to confirm that the 
processes of attention and memory decline with the deterioration of the 
immune system. Therefore, we consider that the deterioration of the 
immune system can be regarded as a risk factor for neuropsychological 
manifestations in seropositive former drug addicts during the different 
stages of the infection. These results provide necessary advances in this 
field, and studies in this way will have to be conitnued in order to keep 
working towards the progress of knowledge in the affectation of the 
lymphocyte T CD4 rate on HIV+ patients.
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